CClinicalTrials.gg
CompletedNCT01055665Updated May 3, 2012

Cognitive Behavioral Therapy, Self-Efficacy, and Depression in Persons With Chronic Pain

An observational study in Depression, sponsored by Mayo Clinic. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2012-05-03.

Sponsored by Mayo Clinic · Observational

Study type
Observational
Time perspective
Retrospective
Enrollment
138
Ages
18 Years and older
Sex
All
01

Study summary

The investigators are exploring the role of Cognitive Behavioral Therapy (CBT), a treatment for depression, on self-efficacy (feeling empowered to accomplish a given task) and depression in persons with chronic pain and depression. Past research has shown that persons with chronic pain show improvement in self-efficacy and depression scores when they are using CBT. The Pain rehabilitation Center (PRC) at Mayo Clinic is adding CBT focused groups to better understand the role of CBT on self-efficacy and depression in persons with chronic pain and depression.

Read the detailed description

Subjects will need to complete two questionnaires on admission and on discharge from the PRC program to measure self-efficacy and depression. The first is the Pain Self-Efficacy Scale (PSEQ) which is a measure of self-efficacy in persons with chronic pain. The second questionnaire is the Center for Epidemiologic Studies Depression Scale (CES-D) which is a measure of depressive symptoms in persons with chronic pain. Both scales will also be used for clinical information. Persons who score 27 or higher on the CES-D will be approached for potential consent to this evidence based project. Each patient in the PRC will participate in up to 6 CBT sessions but only persons who, upon admission, score 27 or greater on the CES-D will be studied for any changes in scores from admission to discharge.

02

Conditions studied

03

In context

Chronic Pain

2,930 studies on the registry are indexed under Chronic Pain; 699 are open to participants now.

This study's enrollment of 138 is close to the median of 126 across 687 observational studies indexed under Chronic Pain.

Browse Chronic Pain studies →

Lead sponsor

Mayo Clinic is the lead sponsor of 3,218 studies on the registry; 670 are open to participants now.

Of its 445 completed or terminated interventional studies of FDA-regulated products, 313 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Persons with chronic pain and depressive symptoms in a pain rehabilitation program.

Inclusion criteria

  • 18 and over with chronic pain and
  • score of 27 or higher on CES-D scale

Exclusion criteria

Exclusion Criteria:

  • 17 or younger, no chronic pain,
  • cognitively unable to participate in programming
05

Study design

Time perspective
Retrospective
Enrollment
138 participants (actual)

Interventions

  • Othercognitive behavior therapy

    6 cognitive behavior therapy groups

06

What researchers measure

Primary outcomes

  1. Change on a depression and self-efficacy scale

    Time frame: 3 weeks

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 3, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01055665
Lead sponsor
Mayo Clinic
Responsible party
Virginia Nash (RN, Clinical Nurse Specialist, Mayo Clinic) — Principal investigator
First posted
Jan 25, 2010
Start date
Oct 2009
Primary completion
Jun 2010
Completion
Jun 2010
Last update
May 3, 2012

Study contacts

Virginia R Nash, RN, MS, CNS
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion